Lexicon Pharmaceuticals Stock Analysis

Lexicon Stock Analysis Notes

About 82.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.63. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lexicon Pharmaceuticals recorded a loss per share of 0.74. The entity had not issued any dividends in recent years. The firm had 1:7 split on the 21st of May 2015. Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas. Lexicon Pharmaceutcl operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. To find out more about Lexicon Pharmaceuticals contact Lonnel Coats at 281 863 3000 or learn more at https://www.lexpharma.com.

Lexicon Pharmaceuticals Investment Alerts

Lexicon Pharmaceuticals Upcoming and Recent Events

Lexicon Largest EPS Surprises

View All Earnings Estimates

Lexicon Stock Institutional Investors

Note, although Lexicon Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Lexicon Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 290.97 M.

Lexicon Profitablity

Management Efficiency

Lexicon Pharmaceuticals has return on total asset (ROA) of (0.4416) % which means that it has lost $0.4416 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3609) %, meaning that it created substantial loss on money invested by shareholders. Lexicon Pharmaceuticals' management efficiency ratios could be used to measure how well Lexicon Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.91 in 2024. Return On Capital Employed is likely to rise to -0.82 in 2024. At this time, Lexicon Pharmaceuticals' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 104.9 M in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 786.6 K in 2024.

Technical Drivers

As of the 1st of December, Lexicon Pharmaceuticals secures the Standard Deviation of 6.12, risk adjusted performance of (0.11), and Mean Deviation of 3.69. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lexicon Pharmaceuticals, as well as the relationship between them.

Lexicon Pharmaceuticals Price Movement Analysis

Lexicon Pharmaceuticals Insider Trading Activities

Lexicon Pharmaceuticals Outstanding Bonds

Lexicon Pharmaceuticals Predictive Daily Indicators

Lexicon Pharmaceuticals Forecast Models

Lexicon Pharmaceuticals' time-series forecasting models are one of many Lexicon Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lexicon Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Lexicon Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lexicon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lexicon Pharmaceuticals. By using and applying Lexicon Stock analysis, traders can create a robust methodology for identifying Lexicon entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Lexicon analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Lexicon analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Lexicon Pharmaceuticals stock analysis indicators help investors evaluate how Lexicon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Lexicon Pharmaceuticals shares will generate the highest return on investment. By understating and applying Lexicon Pharmaceuticals stock analysis, traders can identify Lexicon Pharmaceuticals position entry and exit signals to maximize returns.

When running Lexicon Pharmaceuticals' price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.